HLB Life Science Co., Ltd. (KOSDAQ:A067630) agreed to acquire 14% stake in HLB Co., Ltd. from Jinyanggon, Hyuna Lee, Hyunsoo Lee, Alex S. Kim, Yongwoong Kim and Coughing season on November 5, 2019.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21,400 KRW | -1.15% | +0.94% | +86.90% |
Mar. 22 | HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8% | MT |
Mar. 21 | HLB Life Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+86.90% | 1.7B | |
+15.96% | 70.86B | |
+11.01% | 27.37B | |
-1.96% | 8.14B | |
+1.91% | 7.92B | |
-25.90% | 7.51B | |
+1.40% | 4.65B | |
+3.37% | 4.12B | |
+13.69% | 4.08B | |
-3.52% | 3.92B |
- Stock
- Equities
- Stock HLB Life Science Co., Ltd. - Korea S.E.
- News HLB Life Science Co., Ltd.
- HLB Life Science Co., Ltd. agreed to acquire 14% stake in HLB Co., Ltd. from Jinyanggon, Hyuna Lee, Hyunsoo Lee, Alex S. Kim, Yongwoong Kim and Coughing season.